A case of relapsed acute myeloid leukemia mimicking acute otomastoiditis

被引:0
|
作者
Negara, Ivan [1 ,2 ,3 ]
Chemencedji, Inga [2 ]
Dobrovolschi, Natalia [2 ]
Sporis, Natalia [1 ]
Buruiana, Sanda [1 ]
Vinogradov, Igor [2 ]
机构
[1] Nicolae Testemitanu State Univ Med & Pharm, Kishinev, Moldova
[2] Inst Oncol, Kishinev, Moldova
[3] Nicolae Testemitanu State Univ Med & Pharm, Stefan Cel Mare & Sfant Blvd 165, Kishinev, Moldova
来源
CLINICAL CASE REPORTS | 2024年 / 12卷 / 04期
关键词
acute myeloid leukemia; hematology; mastoiditis; myeloid sarcoma; oncology; relapse; GRANULOCYTIC SARCOMA; TEMPORAL BONE;
D O I
10.1002/ccr3.8717
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Key Clinical MessageIdentifying myeloid sarcoma in rare locations is a diagnostic challenge and requires careful evaluation. The optimal management of extramedullary disease requires further investigation, but tissue biopsy and a personalized approach are crucial.AbstractHerein, we describe an unusual case of acute myeloid leukemia presenting with an isolated involvement of the temporal bone after a complete remission of systemic disease for more than a year. The clinical, radiological, and pathological features are discussed, highlighting the importance of considering differential diagnoses and appropriate management. A computed tomography scan reveals a complete homogenous left-sided and partial right-sided opacification of the mastoid cells and the middle ear with a relatively intact bony structure and no distinct masses.image
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Cytomegalovirus meningitis in a patient with relapsed acute myeloid leukemia
    Harada, Kaito
    Sekiya, Noritaka
    Ikegawa, Shuntaro
    Sasaki, Shugo
    Kobayashi, Takeshi
    Ohashi, Kazuteru
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (02) : 233 - 238
  • [32] Progress in the problem of relapsed or refractory acute myeloid leukemia
    Mims, Alice S.
    Blum, William
    CURRENT OPINION IN HEMATOLOGY, 2019, 26 (02) : 88 - 95
  • [33] Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia
    Goswami, Meghali
    Gui, Gege
    Dillon, Laura W.
    Lindblad, Katherine E.
    Thompson, Julie
    Valdez, Janet
    Kim, Dong-Yun
    Ghannam, Jack Y.
    Oetjen, Karolyn A.
    Destefano, Christin B.
    Smith, Dana M.
    Tekleab, Hanna
    Li, Yeusheng
    Dagur, Pradeep
    Hughes, Thomas
    Marte, Jennifer L.
    del Rivero, Jaydira
    Klubo-Gwiezdzinksa, Joanna
    Gulley, James L.
    Calvo, Katherine R.
    Lai, Catherine
    Hourigan, Christopher S.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (01)
  • [34] The Genetic Landscape of Relapsed Pediatric Acute Myeloid Leukemia
    Umeda, Masayuki
    Ma, Jing
    Hagiwara, Kohei
    Westover, Tamara
    Walsh, Michael P.
    Song, Guangchun
    Liu, Yanling
    Chen, Xiaolong
    Kolekar, Pandurang
    Tran, Quang
    Foy, Scott
    Maciaszek, Jamie L.
    Liu, Yen-Chun
    Hiltenbrand, Ryan
    Miller, Jonathan
    Rusch, Michael
    Wu, Gang
    Inaba, Hiroto
    Mullighan, Charles G.
    Zhang, Jinghui
    Rubnitz, Jeffrey E.
    Ma, Xiaotu
    Klco, Jeffery M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S282 - S282
  • [35] Pediatric relapsed acute myeloid leukemia: a systematic review
    Hoffman, Anne E.
    Schoonmade, Linda J.
    Kaspers, Gertjan J. L.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (01) : 45 - 52
  • [36] Changes of the Mutational Landscape in Relapsed Acute Myeloid Leukemia
    Rapaport, Franck
    de Massy, Marc Robert
    al Hinai, Adil
    Sanders, Mathijs A.
    Hricik, Todd
    Sheridan, Caroline
    Lee, Tak C.
    Neelamraju, Yaseswini
    Patel, Jay
    Chung, Stephen S.
    Becker, Michael W.
    Lewis, Ian D.
    D'Andrea, Richard
    Bullinger, Lars
    Dohner, Konstanze
    Dohner, Hartmut
    Guzman, Monica L.
    Roboz, Gail J.
    Carroll, Martin
    Park, Christopher Y.
    Mason, Christopher E.
    Melnick, Ari
    Levine, Ross L.
    Valk, Peter J. M.
    Garrett-Bakelman, Francine E.
    BLOOD, 2016, 128 (22)
  • [37] Cytomegalovirus meningitis in a patient with relapsed acute myeloid leukemia
    Kaito Harada
    Noritaka Sekiya
    Shuntaro Ikegawa
    Shugo Sasaki
    Takeshi Kobayashi
    Kazuteru Ohashi
    International Journal of Hematology, 2019, 109 : 233 - 238
  • [38] Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid Leukemia
    Lindblad, Katherine E.
    Thompson, Julie
    Gui, Gege
    Valdez, Janet
    Worthy, Tatyana
    Tekleab, Hanna
    Hughes, Tom
    Goswami, Meghali
    Oetjen, Karolyn
    Kim, Dong-Yun
    Dillon, Laura
    DeStefano, Christin
    Lai, Catherine E.
    Hourigan, Christopher S.
    BLOOD, 2018, 132
  • [39] Outcome of Refractory and Relapsed Patients with Acute Myeloid Leukemia
    Niederwieser, Dietger
    Krahl, Rainer
    Kahle, Christoph
    Scholl, Sebastian
    Wolf, Hans-Heinrich
    Cross, Michael
    Hegenbart, Ute
    Peter, Norma
    Niederwieser, Christian
    Florschuetz, Axel
    Reifenrath, Kolja F. B.
    Zojer, Niklas
    Junghanss, Christian
    Sayer, Herbert
    Schmidt, Volker
    Maschmeyer, Georg
    Hochhaus, Andreas
    Fischer, Thomas
    Al-Ali, Haifa Kathrin
    Heinicke, Thomas
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 106 - 106
  • [40] Treatment for relapsed acute myeloid leukemia: what is new?
    Ofran, Yishai
    Rowe, Jacob M.
    CURRENT OPINION IN HEMATOLOGY, 2012, 19 (02) : 89 - 94